CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro

Marisol Blancas-Mosqueda, Pablo Zapata-Benavides, Diana Zamora-Ávila, Santiago Saavedra-Alonso, Edgar Manilla-Muñoz, Moisés Franco-Molina, Carmen Mondragó de la Peña, Cristina Rodríguez-Padilla

Resultado de la investigaciónrevisión exhaustiva


The increased incidence of cancer in recent years is associated with a high rate of mortality. Numerous types of cancer have a low percentage of CD133 + cells, which have similar features to stem cells. The CD133 molecule is involved in apoptosis and cell proliferation. The aim of this study was to determine the biological effect of CD133 suppression and its role in the chemosensitization of cancer cell lines. RT-PCR and immunocytochemical analyses indicated that CD133 was expressed in the cancer cell lines B16F10, MCF7 and INER51. Downregulation of CD133 by transfection with an antisense sequence (As-CD133) resulted in a decrease in cancer cell viability of up to 52, 47 and 22% in B16F10, MCF-7 and INER51 cancer cell lines, respectively. This decreased viability appeared to be due to the induction of apoptosis. In addition, treatment with As-CD133 in combination with cisplatin had a synergic effect in all of the cancer cell lines analyzed, and in particular, significantly decreased the viability of B16F10 cancer cells compared with each treatment separately (3.1% viability for the combined treatment compared with 48% for 0.4 μg As-CD133 and 25% for 5 ng/μl cisplatin; P<0.05). The results indicate that the downregulation of CD133 by antisense is a potential therapeutic target for cancer and has a synergistic effect when administered with minimal doses of the chemotherapeutic drug cisplatin, suggesting that this combination strategy may be applied in cancer treatment.

Idioma originalEnglish
Páginas (desde-hasta)901-905
Número de páginas5
PublicaciónExperimental and Therapeutic Medicine
EstadoPublished - 1 nov 2012
Publicado de forma externa

All Science Journal Classification (ASJC) codes

  • Inmunología y microbiología (miscelánea)
  • Investigación sobre el cáncer


Profundice en los temas de investigación de 'CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro'. En conjunto forman una huella única.

Citar esto